Information  X 
Enter a valid email address

Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLC

By BFN News | 10:30 AM | Monday 04 November, 2019


Liberum Capital today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1890p (from 1510p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t